ACCC's Oncology Drug Reference Guide
ACCC no longer produces the Oncology Drug Reference Guide.
In August 2014, ACCC launched the ACCC Oncology Drug Database, a new comprehensive online resource for the multidisciplinary cancer care team. The Oncology Drug Database provides timely, easily understood, and authoritative information on coding, billing, and reimbursement for oncology drugs. ACCC’s Oncology Drug Database has information for both provider administered (“Part B”) and prescribed (“Part D”) drugs commonly used in treating cancer patients in the ambulatory setting, including both therapeutics and supportive care products, including:
- Billing (HCPCS, NDC) and diagnosis (ICD-9) codes
- Reimbursement amounts
- FDA-approved indications
- Drug manufacturer information, including contactinformation for the medical affairs department and reimbursement specialists (for drugs that remain under patent protection).